American Society of Hematology

Figure 2

$Figure 2. Abundance of stem cells in JAM-A+ and JAM-A− fractions. CD34+c-Kit+ cells in whole cells (left), JAM-A+ cells (middle), and JAM-A− cells (right) were examined by flow cytometry. Enclosures represent percentages of enriched stem-cell fractions that are CD34+c-Kit+ cells in E11.5 AGM (A), E11.5 FL (B), Sca1+ c-Kit+ Lin− cells in E14.5 FL (C), and E18.5 FL (D). Representative data from more than 3 independent experiments are shown. Since these data are dot-plot, there seem to be no CD34+c-Kit− cells. However, the percentage of CD34+c-Kit− cells were 0.89% (± 0.26%) in whole 11.5 AGM and 0.58% (± 0.12%) in whole 11.5 FL, respectively.$

Abundance of stem cells in JAM-A⁺ and JAM-A⁻ fractions. CD34⁺c-Kit⁺ cells in whole cells (left), JAM-A⁺ cells (middle), and JAM-A⁻ cells (right) were examined by flow cytometry. Enclosures represent percentages of enriched stem-cell fractions that are CD34⁺c-Kit⁺ cells in E11.5 AGM (A), E11.5 FL (B), Sca1⁺ c-Kit⁺ Lin⁻ cells in E14.5 FL (C), and E18.5 FL (D). Representative data from more than 3 independent experiments are shown. Since these data are dot-plot, there seem to be no CD34⁺c-Kit⁻ cells. However, the percentage of CD34⁺c-Kit⁻ cells were 0.89% (± 0.26%) in whole 11.5 AGM and 0.58% (± 0.12%) in whole 11.5 FL, respectively.

This Feature Is Available To Subscribers Only